3D生物列印市場：按技術、組件、應用和地區分類

3D Bioprinting Market, By Technology, By Component, By Application, By Geography

出版日期: 2026年03月16日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，3D生物列印市場規模將達到34.4億美元，到2033年將達到100.8億美元。預計從2026年到2033年，其複合年成長率將達到16.6%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	34.4億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	16.60%	2033年市場規模預測：	100.8億美元

3D生物列印是一項新興的創新技術，它利用3D列印機列印人體組織、器官和生物化學物質，用於醫學研究和臨床應用。這項技術透過逐層堆疊活細胞、支架和生長因子來建構生物組織。這種開創性的方法具有巨大的潛力，有望透過解決可移植器官短缺的難題來革新醫學。基於電腦輔助設計，它能夠透過精確地空間沉積生物材料、活細胞和支持因子來創建複雜的3D組織和器官結構。透過複製組織和器官的天然微環境，3D生物列印可以加速再生醫學領域的發展，並最終滿足器官移植的需求。

市場動態

全球3D生物列印市場正受到再生醫學研究領域資金和投入不斷增加的推動。器官移植需求的上升和捐贈者短缺促使人們對生物列印技術提供的替代解決方案加大投資。有利的監管政策和生物列印組織的商業化創造了盈利的市場機會。然而，高昂的營運成本和列印複雜生物結構的技術挑戰仍然是限制因素。缺乏專業技術人員和臨床試驗尚不完善也阻礙了該技術的廣泛應用。儘管如此，各公司正攜手合作，致力於改進生物材料、細胞相容性和3D生物列印機的解析度。藥物動力學測試、個人化藥物篩檢和罕見疾病建模等新興應用領域的出現，預計將在預測期內推動市場成長。

本次調查的主要特點

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球 3D 生物列印市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球 3D 生物列印市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過用於分析全球 3D 生物列印市場的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東和非洲
- 南非
- 海灣合作理事會國家
- 其他中東和非洲國家

第8章競爭情勢

公司簡介
- 3D Bioprinting Solutions
- Advanced Solutions Life Sciences, LLC
- Allevi Inc.
- Aspect Biosystems Ltd.
- Bico group ab
- Bio3D Technologies Pte. Ltd.
- Cellink Global
- Collplant Biotechnologies Ltd.
- Cyfuse Biomedical KK
- Electro Optical Systems
- Envisiontec GmbH
- Foldink Life Science Technologies
- Formlabs, Inc.
- GE Healthcare
- Inventia Life Science PTY LTD
- Nano 3D Biosciences, Inc.
- Optomec Inc.
- Organovo Holdings, Inc.
- Pandorum Technologies pvt. ltd.
- Precise Bio
- Regemat 3D SL
- Regenovo Biotechnology Co. Ltd.
- Renishaw PLC.
- Revotek Co., Ltd.
- Rokit Healthcare, Inc.
- Stratasys Ltd.
- Vivax Bio, LLC

第9章機會分析

機會分析
分析師意見
Coherent Opportunity Map

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI5166

3D Bioprinting Market is estimated to be valued at USD 3.44 Bn in 2026 and is expected to reach USD 10.08 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3.44 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	16.60%	2033 Value Projection:	USD 10.08 Bn

3D bioprinting is an emerging and innovative technology that utilizes 3D printers to print human tissues, organs, and biochemicals for medical research and clinical applications. It works by layering live cells, scaffolds, and growth factors capable of supporting the formation of biological tissues. This pioneering approach holds enormous potential in revolutionizing healthcare by addressing the shortage of transplantable organs. It allows the fabrication of complex 3D tissues and organ structures through precise spatial deposition of biomaterials, living cells, and supporting factors based on computer-assisted design. By replicating the native microenvironment of tissues and organs, 3D bioprinting can accelerate the field of regenerative medicine and ultimately address the demand for organ transplants.

Market Dynamics

The global 3D bioprinting market is driven by rising funding and initiatives for research in regenerative medicines. The growing demand for organ transplants and lack of donors has boosted investments in alternative solutions offered by bioprinting technologies. Favorable regulatory guidelines and commercialization of bioprinted tissues are creating lucrative opportunities. However, high operational costs and technical challenges in printing complex living structures pose constraints. Lack of skilled expertise and clinical trials also challenge widespread adoption. Nonetheless, companies are collaborating to improve biomaterials, cell compatibility, and resolution of 3D bioprinters. The emergence of newer application areas such as pharmacokinetic testing, personalized drug screening, and rare disease modeling can boost the market growth during the forecast period.

Key Features of the Study

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global 3D bioprinting market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include 3D Bioprinting Solutions, Advanced Solutions Life Sciences, LLC, Allevi Inc., Aspect Biosystems Ltd., Bico group ab, Bio3D Technologies Pte. Ltd., Cellink Global, Collplant Biotechnologies Ltd., Cyfuse Biomedical K.K., Electro Optical Systems, Envisiontec GmbH, Foldink Life Science Technologies, Formlabs, Inc., GE Healthcare, Inventia Life Science PTY LTD, Nano 3D Biosciences, Inc., Optomec Inc., Organovo Holdings, Inc., Pandorum Technologies pvt. ltd., Precise Bio, Regemat 3D S.L., Regenovo Biotechnology Co. Ltd., Renishaw plc., Revotek co., ltd., Rokit Healthcare, inc., Stratasys Ltd.Vivax Bio, LLC, and Vivax Bio, LLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global 3D bioprinting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global 3D bioprinting market

Market Segmentation

By Technology (Revenue, USD Bn, 2021 - 2033)
Syringe/extrusion Bioprinting
Inkjet Bioprinting
Magnetic Levitation Bioprinting
Laser-assisted Bioprinting
Others
By Component (Revenue, USD Bn, 2021 - 2033)
3D Bioprinters
Biomaterials
Scaffolds
By Application (Revenue, USD Bn, 2021 - 2033)
Drug Testing and Development
Regenerative Medicine
Food Testing
Research
Others
By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East & Africa
- GCC Countries
- South Africa
- Israel
- Rest of Middle East & Africa
Key Players Insights
3D Bioprinting Solutions
Advanced Solutions Life Sciences, LLC
Allevi Inc.
Aspect Biosystems Ltd.
Bico group ab
Bio3D Technologies Pte. Ltd.
Cellink Global
Collplant Biotechnologies Ltd.
Cyfuse Biomedical K.K.
Electro Optical Systems
Envisiontec GmbH
Foldink Life Science Technologies
Formlabs, Inc.
GE Healthcare
Inventia Life Science PTY LTD
Nano 3D Biosciences, Inc.
Optomec Inc.
Organovo Holdings, Inc.
Pandorum Technologies pvt. ltd.
Precise Bio
Regemat 3D S.L.
Regenovo Biotechnology Co. Ltd.
Renishaw plc.
Revotek co., ltd.
Rokit Healthcare, inc.
Stratasys Ltd.Vivax Bio, LLC
Vivax Bio, LLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Component
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global 3D Bioprinting Market, By Technology, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Syringe/ extrusion bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Inkjet Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Magnetic Levitation Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Laser Assisted Bioprintings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global 3D Bioprinting Market, By Component, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
3D Bioprinters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Biomaterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Scaffolds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global 3D Bioprinting Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Drug Testing and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Food Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global 3D Bioprinting Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Country Trends
North America
- Regional Trends
- Market Size and Forecast, By Technology, 2021-2033 (USD Billion)
- Market Size and Forecast, By Components, 2021-2033 (USD Billion)
- Market Size and Forecast, By Application, 2021-2033 (USD Billion)
- Market Share Analysis, By Country, 2026 and 2033 (%)
  - U.S.
  - Canada
Europe
- Regional Trends
- Market Size and Forecast, By Technology, 2021-2033 (USD Billion)
- Market Size and Forecast, By Components, 2021-2033 (USD Billion)
- Market Size and Forecast, By Application, 2021-2033 (USD Billion)
- Market Share Analysis, By Country, 2026 and 2033 (%)
  - U.K.
  - Germany
  - France
  - Russia
  - Rest of Europe
Asia Pacific
- Regional Trends
- Market Size and Forecast, By Technology, 2021-2033 (USD Billion)
- Market Size and Forecast, By Components, 2021-2033 (USD Billion)
- Market Size and Forecast, By Application, 2021-2033 (USD Billion)
- Market Share Analysis, By Country, 2026 and 2033 (%)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Regional Trends
- Market Size and Forecast, By Technology, 2021-2033 (USD Billion)
- Market Size and Forecast, By Components, 2021-2033 (USD Billion)
- Market Size and Forecast, By Application, 2021-2033 (USD Billion)
- Market Share Analysis, By Country, 2026 and 2033 (%)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East & Africa
- Market Size and Forecast, By Technology, 2021-2033 (USD Billion)
- Market Size and Forecast, By Components, 2021-2033 (USD Billion)
- Market Size and Forecast, By Application, 2021-2033 (USD Billion)
- Market Share Analysis, By Country/region, 2026 and 2033 (%)
  - South Africa
  - GCC Countries
  - Rest of the Middle East & Africa

8. Competitive Landscape

Company Profiles
- 3D Bioprinting Solutions
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Advanced Solutions Life Sciences, LLC
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Allevi Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Aspect Biosystems Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Bico group ab
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Bio3D Technologies Pte. Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Cellink Global
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Collplant Biotechnologies Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Cyfuse Biomedical K.K.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Electro Optical Systems
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Envisiontec GmbH
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Foldink Life Science Technologies
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Formlabs, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- GE Healthcare
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Inventia Life Science PTY LTD
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Nano 3D Biosciences, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Optomec Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Organovo Holdings, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Pandorum Technologies pvt. ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Precise Bio
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Regemat 3D S.L.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Regenovo Biotechnology Co. Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Renishaw PLC.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Revotek Co., Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Rokit Healthcare, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Stratasys Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Vivax Bio, LLC
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates